Technical Analysis for KALA - Kala Pharmaceuticals, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 7.70 | 2.26% | 0.17 |
KALA closed up 2.26 percent on Monday, March 18, 2024, on 85 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Shooting Star Candlestick | Bearish | 0.00% | |
Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
BB Squeeze + Upper Band Touch | Range Contraction | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 2.26% | |
BB Squeeze Started | Range Contraction | 2.26% | |
Gapped Down | Weakness | 2.26% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 0.92% |
Alert | Time |
---|---|
Upper Bollinger Band Resistance | about 15 hours ago |
Rose Above Upper Bollinger Band | about 16 hours ago |
Up 5% | about 16 hours ago |
Up 1 ATR | about 16 hours ago |
Rose Above Previous Day's High | about 16 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/01/2024
Kala Pharmaceuticals Inc. is a United States-based company that is developing ophthalmic treatments based on the Company’s Mucosal Penetrating Product (MPP) platform. The Company’s topical ocular MPP formulations enhance penetration of diverse therapeutic agents into ocular tissue, including those in the back of the eye, by facilitating penetration through the mucus layer of tear film. Its product development pipeline includes a 1% formulation of loteprednol etabonate to treat post-surgical ocular inflammation and pain; a 0.25% LE-MPP formulation for dry eye, blepharitis, and retinal disease, and a topically applied receptor tyrosine kinase inhibitir (RTKi-MPP) for the treatment of wet age-related macular degeneration (AMD).
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pain Organ Systems Eye Inflammation Ophthalmic Macular Degeneration Tyrosine Kinase Retina Wet Age Related Macular Degeneration Glucocorticoids Receptor Tyrosine Kinase Retinal Disease Blepharitis Post Surgical Ocular Inflammation
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pain Organ Systems Eye Inflammation Ophthalmic Macular Degeneration Tyrosine Kinase Retina Wet Age Related Macular Degeneration Glucocorticoids Receptor Tyrosine Kinase Retinal Disease Blepharitis Post Surgical Ocular Inflammation
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 19.5699 |
52 Week Low | 5.1 |
Average Volume | 31,811 |
200-Day Moving Average | 9.89 |
50-Day Moving Average | 7.38 |
20-Day Moving Average | 7.44 |
10-Day Moving Average | 7.57 |
Average True Range | 0.38 |
RSI (14) | 55.75 |
ADX | 38.04 |
+DI | 28.51 |
-DI | 7.83 |
Chandelier Exit (Long, 3 ATRs) | 7.10 |
Chandelier Exit (Short, 3 ATRs) | 7.92 |
Upper Bollinger Bands | 7.95 |
Lower Bollinger Band | 6.93 |
Percent B (%b) | 0.76 |
BandWidth | 13.59 |
MACD Line | 0.11 |
MACD Signal Line | 0.09 |
MACD Histogram | 0.0233 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 8.27 | ||||
Resistance 3 (R3) | 8.31 | 8.16 | 8.18 | ||
Resistance 2 (R2) | 8.16 | 8.01 | 8.14 | 8.15 | |
Resistance 1 (R1) | 7.93 | 7.92 | 8.04 | 7.89 | 8.12 |
Pivot Point | 7.77 | 7.77 | 7.83 | 7.75 | 7.77 |
Support 1 (S1) | 7.54 | 7.63 | 7.66 | 7.51 | 7.28 |
Support 2 (S2) | 7.39 | 7.54 | 7.37 | 7.25 | |
Support 3 (S3) | 7.16 | 7.39 | 7.22 | ||
Support 4 (S4) | 7.13 |